BICX.jpg
BioCorRx Provides Business Update for the First Quarter of 2021
18 mai 2021 09h05 HE | BioCorRx Inc
ANAHEIM, CA, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of...
BICX.jpg
BioCorRx Receives FDA Clearance of Investigational New Drug (IND) Application for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
10 mai 2021 08h30 HE | BioCorRx Inc
ANAHEIM, CA, May 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of...
BICX.jpg
BioCorRx Announces Submission of IND Application to the FDA for BICX104, Implantable Naltrexone
13 avr. 2021 08h00 HE | BioCorRx Inc
ANAHEIM, CA, April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx” or the “Company”), a developer and provider of advanced solutions in the treatment of...
BICX.jpg
BioCorRx Provides 2020 Year-End Business Update
01 avr. 2021 08h30 HE | BioCorRx Inc
ANAHEIM, CA, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BICX.jpg
BioCorRx Completes $2.25 Million Private Placement
02 mars 2021 09h24 HE | BioCorRx Inc
ANAHEIM, CA, March 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BICX.jpg
BioCorRx Appoints Finance Veteran Joseph J. Galligan to the Board of Directors
24 févr. 2021 08h30 HE | BioCorRx Inc
ANAHEIM, CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BICX.jpg
BioCorRx Partners with Truusight Health to Integrate Recovery Program Into Self-Funded Health Plans
13 oct. 2020 08h30 HE | BioCorRx Inc
ANAHEIM, CA, Oct. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (“BioCorRx®”) (“Company”), a developer and provider of advanced solutions in the treatment of substance...
BICX.jpg
BioCorRx Provides Business Update for the Second Quarter of 2020
14 août 2020 08h30 HE | BioCorRx Inc
ANAHEIM, CA, Aug. 14, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BICX.jpg
BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic
22 mai 2020 08h30 HE | BioCorRx Inc
ANAHEIM, CA, May 22, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
BICX.jpg
BioCorRx Offers Free Access to the UnCraveRx™ Mobile Platform for Weight Loss Management During COVID-19 Pandemic
10 avr. 2020 08h30 HE | BioCorRx Inc
ANAHEIM, CA, April 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...